[Recession Proof] They can’t make this fast enough

May 27th, 2024 Hello , We thought this was going to be big a year ago. This news could signal it’s one of our most successful calls ever. A little over a year ago Eli Lilly (LLY) announced a $3.7 billion project in Indiana. The company needed more tirzepatide (the drug marketed as Zepbound and Mounjaro) and it needed it fast. We took the aggressive investment as a major sign of confidence that the [not-so-subtle push for weight-loss drugs]( was working. But that was more than a year ago. Things must have gotten even better since then. Late last week Eli Lilly announced it would be adding $5.3 billion to the production expansion. That’s another huge step and an undeniable weight-loss drug sales trouncing expectations. That’s a good sign considering where 2024 is on this growth curve: The weight-loss drug boom is big, but it’s still in its early stages. [Click here to see how this boom is set to be “bigger for longer.”]( [READ MORE]( “Game-Changing” Discovery That Ignites New Mineral Rush World’s second largest gold company has already made a massive investment in the region. One small company has emerged with a claim in the center of it all. [Click here to here to get our free report]( Dynamic Wealth Research 2010 West Avenue K #623 Lancaster, California 93536 © 2024 | All rights reserved. [Unsubscribe](. [Twitter] [Facebook] [Instagram]